Trials / Recruiting
RecruitingNCT06443281
Pain Phenotyping in Patients With Neuropathic Pain After Spinal Cord Injury
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- University of Zurich · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The development of neuropathic pain is one of the most debilitating sequels after a spinal cord injury (SCI). The overall aim of this study is to investigate potential underlying pathophysiological mechanisms of neuropathic pain after SCI. The functionality of the nociceptive pathway in humans as well as its plastic changes following SCI will be inferred with sophisticated sensory and pain phenotyping using quantitative sensory testing (i.e., psychophysical measures), objective neurophysiological measures of pain processing and the recording of pain-related autonomic responses (i.e., galvanic skin response, cardiovascular measures and pupil dilation). In addition, the interplay between the somatosensory and autonomic nervous system and its association with the development and maintenance of neuropathic pain after SCI will be investigated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Neurophysiology | Pain-related evoked potentials and nerve conduction studies |
| DIAGNOSTIC_TEST | Cardiovascular test | Blood pressure control, orthostatic intolerance test, baro-reflex sensitivity, heart-rate variability |
| DIAGNOSTIC_TEST | Experimental pain paradigms | Temporal summation of pain, conditioned pain modulation |
| DIAGNOSTIC_TEST | Quantitative sensory testing | Thermal and mechanical sensory testing |
| DIAGNOSTIC_TEST | Clinical pain phenotype | Pain drawings, plus and minus signs of pain |
Timeline
- Start date
- 2024-04-17
- Primary completion
- 2030-04-30
- Completion
- 2030-04-30
- First posted
- 2024-06-05
- Last updated
- 2025-12-02
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT06443281. Inclusion in this directory is not an endorsement.